2017, Number 4
<< Back
Rev Latin Infect Pediatr 2017; 30 (4)
Fulminant septic shock from Streptococcus agalactiae. A case presentation
García RMA, Rodríguez ML, Valdés RBD, Valdés RF
Language: Spanish
References: 15
Page: 164-168
PDF size: 388.11 Kb.
ABSTRACT
Streptococcus agalactiae is a gram positive cocci that can be grouped in pairs or short chains; it is a facultative anaerobe, causative of beta hemolysis, and is usually associated with pathologies in the newborn, such as sepsis (early or late) in up to 90%, pneumonia (40%) and meningitis (30%). Serotype III causes more than two thirds of the cases of neonatal disease; 15% of the isolates of this serotype in Mexico are related to high virulence strains. The rate of genital colonization in Latin America varies from two to 20.4%; in Mexico the isolation of serotype III occurs in 32.9%, with incidence of serious neonatal infection from 0.3% to 1%. We report the case of a 26-day-old newborn, who began her illness with nonspecific symptomatology and within a few hours developed a febrile syndrome with septic shock, cardiomyopathy and death a few hours after the onset of symptoms. Risk factors, preventive measures described by consensus, clinical evolution of the condition and clinical manifestations derived from its pathophysiology are analyzed.
REFERENCES
Baker C. Red book atlas of pediatric infectious diseases. 2nd ed. Illinois: American Academy of Pediatrics; 2008.
El Beitune P, Duarte G, Maffei C. Colonization by Streptococcus agalactiae during pregnancy: maternal and perinatal prognosis. Braz J Infect Dis. 2005; 9 (4): 276-282.
Cruz OM, Doren VA, Tapia IJ, Abarzúa CF. Sepsis neonatal por Streptococcus grupo B. Rev Chil Pediatr. 2008; 79 (5): 462-470.
Freitas FT, Romero GA. Early-onset neonatal sepsis and the implementation of group B Streptococcus prophylaxis in a Brazilian maternity hospital: a descriptive study. Braz J Infect Dis. 2017; 21 (1): 92-97.
Palacios-Saucedo GC, Hernández-Hernández TI, Rivera-Morales LG, Briones-Lara E, Caballero-Trejo A, Vázquez-Guillén JM et al. Infección perinatal por estreptococo del grupo B: panorama global, en América Latina y en México. Gac Med Mex. 2017; 153: 361-370.
Miura E, Martin M. Group B streptococcal neonatal infections in Rio Grande do Sul, Brazil. Re Ins Med Tro São Paulo. 2001; 43 (5): 243-246.
Money D, Allen A. Prevention of early-onset neonatal group B streptococcal disease. J Obstet Gynaecol Can. 2013; 35 (10): 939-948.
Apgar BS, Greenberg G, Yen G. Prevention of group B Streptococcal disease in the newborn, University of Michigan Medical School, Ann Arbor, Michigan. Am Fam Physician. 2005; 71 (5): 903-910.
Schuchat A, Wenger JD. Epidemiology of group B streptococcal disease. Risk factors, prevention strategies, and vaccine development. Epidemiol Rev. 1994; 16 (2): 374-402.
Winram S, Mechthild J, Chi E, Rubens CE. Characterization of group B streptococcal invasion of human chorion and amnion epithelial cells in vitro. Infect Immun. 1998; 66 (19): 4932-4941.
Soriani M, Santi I, Taddei A, Rappuoli R, Grandi G, Telford JL. Group B Streptococcus crosses human epithelial cells by a paracellular route. J Infect Dis. 2006; 193 (2): 241-250.
Morin L, Ray S, Wilson C, Remy S, Benissa M, Jansen N et al. Refractory septic shock in children: a European Society of Paediatric and Neonatal Intensive Care definition. Intensive Care Medicine. 2016; 42 (12): 1948-1957.
Leclerc F, Leteurtre S, Duhamel A, Grandbastien B, Proulx F, Martinot A et al. Cumulative influence of organ dysfunctions and septic state on mortality of critically ill children. Am J Respir Crit Care Med. 2005; 171 (4): 348-353.
Seemann A, Boissier F, Razazi K, Carteaux G, de Prost N, Brun-Buisson C et al. New-onset supraventricular arrhythmia during septic shock: prevalence, risk factors and prognosis. Annals of Intensive Care. 2015; 5: 27.
Regueira T, Andresen M, Djafarzadeh S. Disfunción mitocondrial en sepsis, impacto y posible papel regulador del factor inducible por hipoxia (HIF-1α). Medicina Intensiva. 2009; 33 (8); 385-392.
Full text